About NGM Bio
NGM Bio is a private company based in South San Francisco, California, incorporated in 2024 in Delaware. It has reported $142,039,949 raised in one offering on Form D since July 2024. Its chief executive is Diana Bockus.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Jul 5, 2024 | Jul 17, 2024amended Mar 27, 2026 | $142,039,949fully sold | 26 | $5.4M | EquityRule 506(b) | Form D/A ↗1 earlier filing |
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on NGM Bio's Form D filed Mar 27, 2026.
Diana Bockus
Chief Executive Officer and director
TK
RP
PS
Peter Svennilson
Director
Also a director at Carmot Therapeutics, Circle Pharma and Neurona Therapeutics.